Glaspy, J: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells

Wargo, Jennifer A, Schumacher, Lana Y, Comin-Anduix, Begonya, Dissette, Vivian B, Glaspy, John A, McBride, William H, Butterfield, Lisa H, Economou, James S, Ribas, Antoni

Journal:

Cancer Gene Therapy

Year:

2005

Language:

english

File:

PDF, 231 KB

english, 2005

52

Interferon-α induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo

Paquette, R L, Hsu, N, Said, J, Mohammed, M, Rao, N P, Shih, G, Schiller, G, Sawyers, C, Glaspy, J A

Journal:

Year:

2002

Language:

english

File:

PDF, 313 KB

english, 2002

53

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

Glaspy, J, Jadeja, J Singh, Justice, G, Kessler, J, Richards, D, Schwartzberg, L, Rigas, J, Kuter, D, Harmon, D, Prow, D

Journal:

British Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 227 KB

english, 2001

54

Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system

Michael C. Lill, Maureen Lynch, John K. Fraser, Grace Y. Chung, Gary Schiller, John A. Glaspy, Lawrence Souza, Gayle C. Baldwin, Judith C. Gasson

Journal:

Year:

1994

Language:

english

File:

PDF, 926 KB

english, 1994

55

The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma

Kathleen M. Beusterien, Stacey J. Ackerman, Kathryn Plante, John Glaspy, Peter Naredi, Diana Wood, Kurt Gehlsen, Sanjiv S. Agarwala

Journal:

Supportive Care in Cancer

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

56

Reproductive success of three passerine species exposed to dioxin-like compounds near Midland, Michigan, USA

Timothy B. Fredricks, Matthew J. Zwiernik, Rita M. Seston, Sarah J. Coefield, Cassandra N. Glaspie, Dustin L. Tazelaar, Denise P. Kay, John L. Newsted, John P. Giesy

Journal:

Year:

2012

Language:

english

File:

PDF, 265 KB

english, 2012

57

Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma

Lynn K Gordon, Antoni Ribas, Steven Nusinowitz, Lisa H Butterfield, John A Glaspy, James S Economou, Bradley R Straatsma

Journal:

Controlled Clinical Trials

Year:

2004

Language:

english

File:

PDF, 247 KB

english, 2004

58

Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery

Ronald L. Paquette, Sanaa T. Dergham, Ellen Karpf, He-Jing Wang, Dennis J. Slamon, Larry Souza, John A. Glaspy

Journal:

Experimental Hematology

Year:

2002

Language:

english

File:

PDF, 155 KB

english, 2002

59

Acupuncture: Evidence and Implications for Cancer Supportive Care

Joannie Shen, John Glaspy

Journal:

Cancer Practice

Year:

2001

Language:

english

File:

PDF, 410 KB

english, 2001

60

Therapeutic options in the management of renal cell carcinoma

Journal:

Seminars in Oncology

Year:

2002

Language:

english

File:

PDF, 78 KB

english, 2002

61

Use of complementary/alternative therapies by women with advanced-stage breast cancer

Joannie Shen, Ronald Andersen, Paul S Albert, Neil Wenger, John Glaspy, Melissa Cole, Paul Shekelle

Journal:

BMC Complementary and Alternative Medicine

Year:

2002

Language:

english

File:

PDF, 352 KB

english, 2002

62

A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01)

Sara A. Hurvitz, Heather J. Allen, Rebecca L. Moroose, David Chan, Christopher Hagenstad, Steven H. Applebaum, Giribala Patel, Eddie H. Hu, Nancy Ryba, Lii-Shin Lin, HeJing Wang, John Glaspy, Dennis J

Journal:

Clinical Breast Cancer

Year:

2010

Language:

english

File:

PDF, 598 KB

english, 2010

63

Clinical Benefits of Epoetin Alfa Therapy in Patients with Lung Cancer

Jeffrey Crawford, George D. Demetri, Janice L. Gabrilove, Michael V. Blasi, Brenda J. Sarokhan, John Glaspy

Journal:

Clinical Lung Cancer

Year:

2002

Language:

english

File:

PDF, 177 KB

english, 2002

64

Whole-Body Positron Emission Tomography with (Fluorine-18)-2-Deoxyglucose Can Detect Metastatic Carcinoma of the Fallopian Tube

Beth Y. Karlan, Carl Hoh, Nielson Tse, Robert Futoran, Randall Hawkins, John Glaspy

Journal:

Gynecologic Oncology

Year:

1993

File:

PDF, 717 KB

1993

65

Whole-Body Positron Emission Tomography with 2-[18F]-Fluoro-2-deoxy-D-glucose Can Detect Recurrent Ovarian Carcinoma

Beth Y. Karlan, Randall Hawkins, Carl Hoh, Margaret Lee, Nielson Tse, Patricia Cane, John Glaspy

Journal:

Gynecologic Oncology

Year:

1993

File:

PDF, 452 KB

1993

66

233 A phase IV study of epoetin alfa examining clinical outcomes in anaemic cancer patients receiving chemotherapy

J. Glaspy, R. Bukowski, D. Steinberg, C.W. Taylor, S. Vadhan-Raj, R.E. Danna, B. Sarokhan, L. Lonczak, M. McNeill

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 166 KB

english, 1995

67

Surveillance of the Eye and Vision in Clinical Trials of CP-675,206 for Metastatic Melanoma

Bradley R. Straatsma, Steven Nusinowitz, Tara A. Young, Lynn K. Gordon, Melissa W. Chun, Colleen Rosen, Elisabeth Seja, James S. Economou, John A. Glaspy, Viviana Bozon, Jesus Gomez-Navarro, Antoni Ri

Journal:

American Journal of Ophthalmology

Year:

2007

Language:

english

File:

PDF, 6.49 MB

english, 2007

68

Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: A randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa

John Glaspy, David Henry, Ravi Patel, Simon Tchekmedyian, Steve Applebaum, Donald Berdeaux, Richard Lloyd, Russell Berg, Matt Austin, Greg Rossi

Journal:

European Journal of Cancer

Year:

2005

Language:

english

File:

PDF, 176 KB

english, 2005

69

The role of positron emission tomography in oncology and other whole-body applications

Randall A. Hawkins, Carl Hoh, John Glaspy, Yong Choi, Magnus Dahlbom, Sheila Rege, Cristina Messa, Egbert Nietszche, Edward Hoffman, Leanne Seeger, Jamshid Maddahi, Michael E. Phelps

Journal:

Seminars in Nuclear Medicine

Year:

1992

Language:

english

File:

PDF, 4.09 MB

english, 1992

70

Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer

William J Aronson, John A Glaspy, Srinivasa T Reddy, David Reese, David Heber, Dilprit Bagga

Journal:

Year:

2001

Language:

english

File:

PDF, 182 KB

english, 2001

71

Clinical update: intravenous iron for anaemia

Michael Auerbach, Harold Ballard, John Glaspy

Journal:

Year:

2007

Language:

english

File:

PDF, 68 KB

english, 2007

72

Long-term risks of increased use of intravenous iron – Authors' reply

Michael Auerbach, Harold Ballard, John Glaspy

Journal:

Year:

2007

Language:

english

File:

PDF, 96 KB

english, 2007

73

The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review

Susan D. Ross, Kyle Fahrbach, Diana Frame, Rachel Scheye, Janet E. Connelly, John Glaspy

Journal:

Clinical Therapeutics

Year:

2003

Language:

english

File:

PDF, 1.35 MB

english, 2003

74

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human α-fetoprotein

Wilson S Meng, Lisa H Butterfield, Antoni Ribas, Justin B Heller, Vivian B Dissette, John A Glaspy, William H McBride, James S Economou

Journal:

Molecular Immunology

Year:

2001

Language:

english

File:

PDF, 142 KB

english, 2001

75

Histamine dihydrochloride administered with interleukin-2 increases survival duration in patients with ocular melanoma with liver metastases

S. Agarwala, A. Hauschild, J. Glaspy, K.R. Gehlsen, P. Naredj, S. O'Day

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 186 KB

english, 2001

76

Safety profile of histamine dihydrochloride administered with interleukin-2 in patients with advanced metastatic malignant melanoma

S.J. O'Day, J. Glaspy, E. Whitman, C.L. Kass, K.R. Gehlsen, S.S. Agarwala

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 180 KB

english, 2001

77

High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in California

Lloyd E. Damon, Wendy W. Hu, Keith E. Stockerl-Goldstein, Karl G. Blume, Jeffrey L. Wolf, Eric Gold, Gary R. Cecchi, David Irwin, John Glaspy, Mary Territo, William Miller, James R. Mason, Charles A.

Journal:

Biology of Blood and Marrow Transplantation

Year:

2000

Language:

english

File:

PDF, 125 KB

english, 2000

78

Status of high-dose chemotherapy for breast cancer: A review

Yago Nieto, Richard E. Champlin, John R. Wingard, James J. Vredenburgh, Anthony D. Elias, Paul Richardson, John Glaspy, Roy B. Jones, Patrick J. Stiff, Scott I. Bearman, Pablo J. Cagnoni, Peter A. McS

Journal:

Biology of Blood and Marrow Transplantation

Year:

2000

Language:

english

File:

PDF, 194 KB

english, 2000

79

Erythropoietins should be used according to guidelines

Matti S Aapro, Gunnar Birgegård, Carsten Bokemeyer, Paul Cornes, Jan Foubert, Pere Gascon, John Glaspy, Eva Hellström-Lindberg, Hartmut Link, Heinz Ludwig, Anders Österborg, Lazzaro Repetto, Pierre So

Journal:

The Lancet Oncology

Year:

2008

Language:

english

File:

PDF, 565 KB

english, 2008

80

Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery

Elizabeth J Shpall, Richard Champlin, John A Glaspy

Journal:

Biology of Blood and Marrow Transplantation

Year:

1998

Language:

english

File:

PDF, 128 KB

english, 1998

81

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

John R Mackey, Miguel Martin, Tadeusz Pienkowski, Janusz Rolski, Jean-Paul Guastalla, Amer Sami, John Glaspy, Eva Juhos, Andrew Wardley, Tommy Fornander, John Hainsworth, Robert Coleman, Manuel R Modi

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 340 KB

english, 2013

82

Epoetin alfa improves hemoglobin levels and quality of life for lung cancer patients receiving chemotherapy

Crawford, J, Glaspy, J, Demetri, G, Gabrilove, J

Journal:

Year:

2000

Language:

english

File:

PDF, 110 KB

english, 2000

83

548 CERA (Continuous erythropolesis receptor activator) is an innovative erythropoietic agent with an extended serum half-life: studies of mode of action, pharmacokinetics and erythropoietic activity

A. Haselbeck, B. Reigner, P. Jordan, A. Pannier, J. Glaspy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

84

568 Phase I studies with CERA (Continuous Erythropoiesis Receptor Activator), an innovative erythropoietic agent

B. Reigner, P. Jordan, A. Pannier, J. Glaspy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

85

Darbepoetin alfa given once every 3 weeks (Q3W) either synchronously or asynchronously with Q3W chemotherapy (ctx) improves anaemia in patients with breast cancer: results of a randomised, open-label study

M Rahn Kim, J Glaspy, D Henry, R Patel, N.S Tchekmedyian, R Berg

Journal:

European Journal of Cancer Supplements

Year:

2004

Language:

english

File:

PDF, 171 KB

english, 2004

86

1120 POSTER Evaluation of the association between hemoglobin (Hb) events and safety outcomes in cancer patients (pts) with chemotherapy-induced anemia (CIA): an integrated analysis of patient-level data from 6 randomized, placebo-controlled trials (RCTs) of darbepoetin alfa (DA)

J. Glaspy, A. Österborg, H. Ludwig, A. Fleishman, T. Lillie, T. Süto, J. Crawford

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 79 KB

english, 2007

87

1104 POSTER Patient-level integrated analysis of data from 6 randomized, double-blind, placebo-controlled trials of darbepoetin alfa (DA) in patients (pts) with chemotherapy-induced anemia (CIA)

H. Ludwig, J. Crawford, A. Österborg, A. Fleishman, T. Lillie, T. Süto, J. Glaspy

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 75 KB

english, 2007

88

1139 POSTER Treatment patterns and patient characteristics associated with treatment for chemotherapy-induced anaemia in community-based oncology practices in the U.S.

L. Friedman, A. Naeim, D. Pasta, E. Elkin, H. Viswanathan, J. Glaspy

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 79 KB

english, 2007

89

Phase III clinical trials with darbepoetin: implications for clinicians

Journal:

Best Practice & Research Clinical Haematology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

90

Intravenous iron in chemotherapy and cancer-related anemia

Michael Auerbach, April S. Liang, John Glaspy

Journal:

Community Oncology

Year:

2012

Language:

english

File:

PDF, 208 KB

english, 2012

91

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses

Vansteenkiste, Johan, Glaspy, John, Henry, David, Ludwig, Heinz, Pirker, Robert, Tomita, Dianne, Collins, Helen, Crawford, Jeffrey

Journal:

Year:

2012

Language:

english

File:

PDF, 670 KB

english, 2012

92

Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint

James J Rusthoven, Elisabeth G.E de Vries, David C Dale, Martine Piccart, John Glaspy, Anne Hamilton

Journal:

International Journal of Antimicrobial Agents

Year:

1997

Language:

english

File:

PDF, 339 KB

english, 1997

93

PCN5 COMPARING THE COST-EFFECTIVENESS OF FRONT-LOADED DARBEPOETIN ALFA WITH EPOETIN ALFA FOR ANEMIA MANAGEMENT IN CHEMOTHERAPY-TREATED CANCER PATIENTS IN UNITED STATES

J Glaspy, N Tchekmedyian, S Gupta

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 67 KB

english, 2002

94

PCN17 COMPARING THE COST-EFFECTIVENESS OF 3 MCG/KG Q2W DARBEPOETIN ALFA WITH STANDARD DOSE EPOETIN ALFA FOR ANEMIA MANAGEMENT IN CHEMOTHERAPY-TREATED CANCER PATIENTS IN UNITED STATES

J Glaspy, N Tchekmedyian, S Gupta

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 63 KB

english, 2002

95

5016 Efficacy in patient subgroups in RIBBON-1, a randomized, double-blind, Phase III trial of chemotherapy with or without bevacizumab (B) for first-line treatment of HER2-negative locally recurrent or metastatic breast cancer (MBC)

V. Dieras, J. Glaspy, A. Brufsky, I. Bondarenko, O. Lipatov, E.A. Perez, S. Chan, X. Zhou, S.C. Phan, N. Robert

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

96

476 PFS by patient subgroup for standard chemotherapies in combination with bevacizumab (BV) in the first-line treatment of HER2-negative locally recurrent (LR) or metastatic breast cancer (mBC): results from RIBBON-1

I. Bondarenko, J. Glaspy, A. Brufsky, O. Lipatov, E.A. Perez, S. Chan, X. Zou, S.C. Phan, N.J. Robert, V. Dieras

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

97

469 Incidence of selected adverse events (AEs) in phase III studies of bevacizumab (BV) in combination with chemotherapy for the treatment of HER2-negative metastatic breast cancer (mBC)

D.W. Miles, V. Dieras, J. Glaspy, A. Brufsky, P. Koralewski, S.C. Phan, N.J. Robert

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 49 KB

english, 2010

98

489 Bevacizumab (BV) in combination with chemotherapy in the treatment of HER2-negative metastatic breast cancer (mBC): PFS subgroup results from two phase III studies

J. Glaspy, V. Dieras, A. Brufsky, D.W. Miles, S.C. Phan, J. O'Shaughnessy

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

99

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

Antoni Ribas, Jason A Chesney, Michael S Gordon, Amy P Abernethy, Theodore F Logan, David H Lawson, Bartosz Chmielowksi, John A Glaspy, Karl Lewis, Bo Huang, Erjian Wang, Poe-Hirr Hsyu, Jesus Gomez-Na

Journal:

Journal of Translational Medicine

Year:

2012

Language:

english

File:

PDF, 207 KB

english, 2012

100

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

Antoni Ribas, Luis H Camacho, Sun Min Lee, Evan M Hersh, Charles K Brown, Jon M Richards, Maria Jovie Rodriguez, Victor G Prieto, John A Glaspy, Denise K Oseguera, Jackie Hernandez, Arturo Villanueva,

Journal:

Journal of Translational Medicine

Year:

2010

Language:

english

File:

PDF, 3.98 MB

english, 2010

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски